Skip to content

Using placenta-derived stem cells for novel medical therapies

Past research has suggested that human placentas are a rich source of stem cells that may prove useful in treating leukemia, heart disease and multiple sclerosis. In this TEDMED 2011 talk, Robert Hariri, MD, PhD, chief executive officer of Cellular Therapeutics Division at Celgene, discusses the challenges and potential benefits of transforming stem cells harvested from the placenta into novel medical therapies for a variety of conditions.

Previously: The placenta sacrifices itself to keep baby healthy in case of starvation, research shows and Program focuses on the treatment of placental disorders
Via Medgadget

Popular posts

Category:
Biomedical research
How do the new COVID-19 vaccines work?

The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.